Abstract CT158: ATHENA (GOG-3020/ENGOT-ov45): a randomized, double-blind, placebo-controlled, Phase III study of rucaparib + nivolumab following front-line platinum-based chemotherapy in ovarian cancer
暂无分享，去创建一个
B. Monk | A. Oza | F. Marmé | I. McNeish | R. Coleman | T. Herzog | S. Westin | S. Goble | R. Eskander | R. Kristeleit | A. Oaknin | T. Safra | D. O’Malley | D. Lorusso | K. Fujiwara | S. Hume | L. Maloney | J. Korach | Lisa Caunt | K. Lin | D. Shih